| |
| |
|
| Insider
Information: |
Foley Mark J |
| Relationship: |
|
| City: |
Pleasanton |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,036,952 |
|
|
Indirect Shares
|
110,913 |
|
|
| Direct
Value |
$6,972,665 |
|
|
|
Indirect Value
|
$368,231 |
|
|
| Total
Shares |
1,147,865 |
|
|
| Total
Value |
$7,340,897 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -32.3%
|
-141.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zeltiq Aesthetics Inc |
ZLTQ |
President and CEO, Dir... |
2017-04-28 |
0 |
2012-04-27 |
0 |
Premium* |
|
|
Revance Therapeutics, Inc. |
RVNC |
CEO, Director |
2024-03-15 |
994,935 |
2024-03-15 |
110,913 |
Premium* |
|
|
Glaukos Corp |
GKOS |
|
2024-02-23 |
33,220 |
2018-05-31 |
0 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
|
2020-06-16 |
8,797 |
2020-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GKOS |
Glaukos Corp |
|
– • – |
2018-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,633 |
4,633 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2019-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,653 |
7,286 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
• • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,900 |
11,186 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,184 |
12,370 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,382 |
14,752 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,486 |
17,238 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,364 |
21,602 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,948 |
24,550 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,230 |
27,780 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-02-23 |
4 |
S |
$92.87 |
$423,487 |
D/D |
(4,560) |
33,220 |
0 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-02-23 |
4 |
OE |
$7.28 |
$72,750 |
D/D |
10,000 |
37,780 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2017-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2017-11-07 |
4 |
B |
$26.95 |
$539,168 |
I/I |
20,000 |
20,000 |
2.1 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
13,500 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2019-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
213,500 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
413,500 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2020-07-23 |
4 |
A |
$0.00 |
$0 |
I/I |
50,913 |
70,913 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2020-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
264,439 |
835,670 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2020-09-30 |
4 |
D |
$25.14 |
$3,601,783 |
D/D |
(143,269) |
571,231 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
301,000 |
714,500 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2020-10-13 |
4 |
D |
$27.62 |
$1,825,848 |
D/D |
(66,106) |
769,564 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,715 |
810,279 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2021-06-30 |
4 |
A |
$24.09 |
$21,246 |
D/D |
882 |
811,161 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO & President |
• • – |
2021-10-13 |
4 |
D |
$23.08 |
$971,576 |
D/D |
(42,096) |
769,065 |
0 |
- |
|
158 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
